one-act look drug suppli
clear yet
contract overhang drug wholesal enter third year face challeng
relat drug price oper earn growth share price perform look
like first half cardin face neg earn risk relat
renew drug suppli contract share largest custom cardin suppli
major retail store suppli balanc store pbm mail
facil contract run june princip suppli brand drug
retail econom gener drug though red oak purchas jv cardin
expect renew contract current partner would expect renew
requir price concess distributor given size contract even modest margin
concess would meaning drag ep growth note
take look potenti earn headwind cardin relat
headwind red bird account cardin total revenu
drug distribut revenu model rang declin profit
contract would headwind pharma segment
oper profit forecast ep would expect repric come higher
end rang potenti limit oper profit growth trim
estim believ repric like hit cardin hardest reduc
ep estim ep estim see ex
target price remain unchang due round
mail account mckesson revenu model
rang declin profit contract would million headwind
us pharma specialti adjust oper profit forecast
ep would expect repric come lower end rang given higher
product facil concentr mail-ord contract
maintain rate maintain rate view
repric contract potenti oper profit driver partial
includ -aet synergi target maintain outperform rate share view
contract renew headwind maintain sector perform rate
greater drag expect
price prior trade day market close estimate unless otherwis note
valu usd unless otherwis note
one-act look drug suppli renew
sail wind take look repric
cardin
three drug wholesal enter third year face challeng relat drug
price oper earn growth share price perform look like
first half two three wholesal cardin face neg earn
risk relat renew drug suppli contract share largest custom
cardin contract come end current three
year deal sign extens deal
cardin suppli major retail store suppli balanc
store caremark pbm mail facil contract run june
princip suppli brand drug retail econom gener drug
though red oak purchas jv cardin form decemb expect
renew contract current partner would expect renew requir
price concess distributor contract tendenc grow
profit time price increas brand drug manufactur contribut
dollar profit growth wholesal recent meet cardin health
execut manag indic contract gener appreci profit like
see pressur repric repres headwind result given size
contract worth billion even modest margin concess would
meaning drag ep growth note take look
potenti earn headwind cardin relat renew
cardin execut recent drew attent repric also allud
save opportun recent present investor present includ slide
expect sourc synergi aetna merger gener administr
categori signific sourc synergi key line item vendor contract
would expect includ repric drug distribut contract
one-act look drug suppli renew
note total categori look slightli million save well
combin million save estim distribut contract
high-end rang assum streamlin corpor function creat
save lion share save bucket could come vendor
contract largest part bucket would drug sourc cost put
cost good perspect estim compani report total cog billion
billion repres cost acquir drug cardin
distribut contract synergi meaning visibl
note merger synergi includ save contract could disappoint
investor cost save would realiz regardless deal
estim oper profit ep growth distributor
lower estim cardin pharma segment reflect repric
headwind cardin forecast declin oper profit
pharma segment growth total adjust oper profit
contract declin profit midpoint forecast
lower forecast requir approxim oper profit growth outsid
relationship pharma segment achiev oper profit declin forecast
segment believ reason forecast improv gener price
start back half continu strength specialti drive improv
profit outsid believ unlik oper profit growth
segment meaning higher
revis forecast adjust oper incom billion well
street forecast billion revis ep estim
also well street forecast expect street estim
come street better model headwind contract repric
drag oper incom growth
one-act look drug suppli renew
cardin health impact profit
exhibit sensit tabl contract repric
trim estim believ repric like hit cardin
hardest reduc ep estim reduc
expect core pharma distribut busi modestli rais outlook
medic segment trim ep estim
reflect lower expect drug segment better result medic note
prior estim drug segment may optimist base recent result
could still high assum consensu yet captur impact
repric estim
oper profit impact ep drag ep drag impact bp revenuerepr impact bp revenuerepr impact bp revenu one-act look drug suppli renew
exhibit even estim may enough
forecast essenti flat oper profit compar
us pharma specialti segment repric offset benefit better
gener price environ specialti growth contract declin profit
midpoint forecast would requir approxim oper
profit growth outsid relationship pharma segment achiev flat
oper profit growth forecast segment view level growth reason
gener price improv specialti growth continu
total adjust oper profit forecast reflect growth
due flat forecast us pharma specialti segment total adjust
oper profit forecast billion street forecast billion
part reflect expect stronger growth ep estim
modestli ahead street forecast higher share repurchas
estim believ less risk street ep forecast compar
street estim oper profit ep alreadi look conserv
segment pharma segment old one-act look drug suppli renew
impact profit
exhibit sensit tabl contract repric
maintain sector perform rate share
maintain rate view repric contract
potenti oper profit driver partial includ -aet
synergi target maintain outperform rate share view contract
renew headwind maintain sector perform rate
greater drag expect
oper profit impact ep drag ep drag impact bp revenuerepr impact bp revenuerepr impact bp one-act look drug suppli renew
good sold
revenu
impair charg net
litig credit net
revenu
adj profit tax
profit tax
weight average number share
one-act look drug suppli renew
